The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. AnaptysBio Inc shares valued at $58,005 were sold by Lizzul Paul F. on Sep 23 ’24. At $38.67 per share, Lizzul Paul F. sold 1,500 shares. The insider’s holdings dropped to 15,398 shares worth approximately $0.5 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, PAUL F LIZZUL purchased 1,500 shares, netting a total of over 58,005 in proceeds.
Before that, LOUMEAU ERIC J had sold 8,720 shares from its account. In a trade valued at $347,270, the CHIEF LEGAL OFFICER traded AnaptysBio Inc shares for $39.82 each. Upon closing the transaction, the insider’s holdings decreased to 8,720 shares, worth approximately $0.23 million.
As published in their initiating research note from H.C. Wainwright on July 22, 2024, AnaptysBio Inc [ANAB] has been a Buy and the price target has been revised to $55. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid July. As of April 16, 2024, Leerink Partners has initiated its “an Outperform” rating for ANAB. Earlier on April 11, 2024, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for ANAB stock.
Analyzing ANAB Stock Performance
During the last five days, there has been a drop of approximately -8.41%. Over the course of the year, AnaptysBio Inc shares have jumped approximately 50.42%. Shares of the company reached a 52-week high of $41.31 on 08/14/24 and a 52-week low of $18.49 on 04/25/24. A 50-day SMA is recorded $35.38, while a 200-day SMA reached $27.89. Nevertheless, trading volume fell to 0.65 million shares from 0.27 million shares the previous day.
Support And Resistance Levels for AnaptysBio Inc (ANAB)
According to the 24-hour chart, there is a support level at 31.13, which, if violated, would cause prices to drop to 30.04. In the upper region, resistance lies at 34.28. The next price resistance is at 36.34. RSI (Relative Strength Index) is 41.44 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.30, which suggests the price will decrease in the coming days. Percent R is at 74.61%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
